日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer.

Josephin结构域包含2 (JOSD2) 抑制作为泛KRAS突变靶向策略治疗结直肠癌

Yuan Tao, Liu Yue, Wu Ruilin, Qian Meijia, Wang Weihua, Li Yonghao, Zhu Hongdao, Wang Jia'er, Ge Fujing, Zeng Chenming, Dai Xiaoyang, Hu Ronggui, Zhou Tianhua, He Qiaojun, Zhu Hong, Yang Bo

VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination-Dependent Degradation.

VCP通过介导BAP1泛素化依赖性降解促进胆管癌发展

Zhang Peiying, Liu Xiangning, Liu Yue, Zhu Hongdao, Zheng Churun, Ling Qi, Yan Fangjie, He Qiaojun, Zhu Hong, Yuan Tao, Yang Bo

The effect of PLK1 inhibitor in osimertinib resistant non-small cell lung carcinoma cells.

PLK1抑制剂对奥希替尼耐药的非小细胞肺癌细胞的影响

Dai Xiaoyang, Liu Xiangning, Ge Fujing, Zhu Hongdao, Zheng Churun, Yan Fangjie, Yang Bo

Exosome Mediated Cytosolic Cisplatin Delivery Through Clathrin-Independent Endocytosis and Enhanced Anti-cancer Effect via Avoiding Endosome Trapping in Cisplatin-Resistant Ovarian Cancer

外泌体通过网格蛋白独立的内吞作用介导细胞浆顺铂输送,并通过避免顺铂耐药卵巢癌中的内体捕获增强抗癌作用

Guannan Zhou, Yuanyuan Gu, Zhongyi Zhu, Hongdao Zhang, Wei Liu, Beiying Xu, Fangyue Zhou, Menglei Zhang, Keqin Hua, Ligang Wu, Jingxin Ding